Dr Joel M. Gelfand | CureTalks
"Joel M. Gelfand is a tenured Professor of Dermatology and of Epidemiology, Vice Chair for Clinical Research (Dermatology), Senior Scholar, Center for Clinical Epidemiology and Biostatistics, Medical Director Clinical Studies Unit in the Department of Dermatology, and Director Psoriasis and Phototherapy Treatment Center, all at the University of Pennsylvania. He is a board certified dermatologist whose clinical work focuses on general dermatology and psoriasis. His research focuses on clinical trials and epidemiology. He has designed/conducted clinical trials to evaluate novel therapies for psoriasis, hidradenitis, and T cell lymphoma. He has published extensively on the epidemiology of psoriasis and psoriatic arthritis, the impact of psoriasis on health related quality of life, and the risk of various co-morbidities such as obesity, diabetes, hyperlipidemia, lymphoma, and myocardial infarction associated with psoriasis. Dr. Gelfand is the author of over 200 research articles, reviews, and text book chapters which have been cited >18,000 times (H index 60) and is a Deputy Editor for the Journal of Investigative Dermatology. Dr. Gelfand received his undergraduate training at Tufts, (BS, Biology, Summa Cum Laude), and his MD from Harvard (Magna Cum Laude). He performed an internship in internal medicine at Mount Sinai Hospital, (NY, NY), and completed his residency in dermatology at PENN where he received a Masters of Science in Clinical Epidemiology. Dr. Gelfand’s research and career are supported by grants from the NIAMS, NHLBI, the American Skin Association, and the Dermatology Foundation. He is a member of the American Academy of Dermatology, the Society for Investigative Dermatology, the American Society for Clinical Investigation (elected member) and the International Society for Pharmacoepidemiology. "
Psoriasis is one of the most common skin ailments, affecting about 2 percent of the population, across gender, age or socioeconomic status. The…